Although vitiligo has traditionally been very difficult to treat, a new breakthrough surgical treatment is expanding options for practitioners and patients.

Standard treatments depend on the severity of the condition and the patient's feelings of disfigurement. Cover-up cosmetics work well for some people. Other more sophisticated forms of treatment include gradually developing color back in the depigmented areas (repigmentation) by PUVA or other ultraviolet light treatments, but this is extremely slow and intensive, often requiring several hundred treatments.

This new form of treatment, which involves surgically transplanting melanocytes into the white areas, is most successful in patients with stable vitiligo over less than 30% of their body surface area. It complements medical therapies in achieving complete and sustained repigmentation and is rapidly gaining popularity in all major centers.

This is the first book available which describes this major advance in detail.

• Explains the new treatment of surgically transplanting melanocytes into the affected areas of the skin to provide dermatologists and surgeons with the latest state-of-the-art information
• Written by the international leaders who pioneered this treatment
• Presents all the latest information on the topic, eliminating the need to search through multiple sources for specific data

Somesh Gupta, MD, DNB, Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.

Mats J. Olsson, PhD, Department of Medical Sciences, Section of Dermatology and Venereology, University Hospital, Uppsala, Sweden.

Amrinder J. Kanwar, MD, Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Jean-Paul Ortonne, MD, Department of Dermatology, Nice University Hospital, Nice, France.